Zhejiang Hisun Pharmaceutical
CompanyChinaFounded 1952
Zhejiang Hisun Pharmaceutical develops one asset, in phase 3 (HS-25 in hypercholesterolemia in coronaory heart disease). Mostly small molecule acting on lipid and ceramide metabolism and NPC1L1; based in China, founded in 1952.
- 1
- Asset
- Furthest stage
- Phase 3
- 2
- Trials
- 0
- Signals
Pipeline
1Cholesterol absorption inhibitor targeting NPC1L1
Phase 3, Small molecule, Lipid and ceramide metabolism, NPC1L1, hypercholesterolemia in coronaory heart disease, primary hypercholesterolemia
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms3
- Trials2
- Integrity notices1
- Similar companies6